---
id: 98
registrationType: 境外生产药品
genericName: 维兰特罗/氟替卡松
productName: 维兰特罗/氟替卡松吸入粉雾剂
productNameEn: Vilanterol/Fluticasone Furoate Inhalation Powder
brandName: 伟思罗
brandNameEn: Relvar
category: 化学药品
formulation: 吸入粉雾剂
specification: 25μg/100μg
registrationNumber: 国药准字HJ20210345
mahName: GlaxoSmithKline Trading Services Limited
mahAddress: 12 Riverwalk, Citywest Business Campus, Dublin 24, Ireland
manufacturerName: Glaxo Operations UK Limited
manufacturerAddress: Priory Street, Ware, Hertfordshire, SG12 0DJ, United Kingdom
manufacturerCountry: 英国
packagingName: 葛兰素史克制药（苏州）有限公司
packagingAddress: 江苏省苏州工业园区苏虹东路200号
approvalDate: 2021-12-01
isOriginal: true
originator: GlaxoSmithKline plc
originatorSource:
  - type: FDA橙皮书
    url: https://www.accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=001&Appl_No=204275
  - type: 企业年报
    url: https://www.gsk.com/en-gb/investors/corporate-reporting/annual-report/
originalException: "原研企业授权苏州工厂分装"
---

## 适应症

1. 支气管哮喘的维持治疗
2. 慢性阻塞性肺疾病的维持治疗
3. 预防哮喘急性发作
4. 改善肺功能

## 注意事项

1. 不用于急性症状的缓解
2. 监测肾上腺功能
3. 注意骨密度降低风险
4. 避免突然停药

## 不良反应

- 口腔念珠菌病
- 上呼吸道感染
- 头痛
- 声音嘶哑
- 心动过速 